Three gene products, including Myc and the D-and E-type G1 cyclins, are rate limiting for G1 progression in mammalian fibroblasts. Quiescent mouse NIH 3T3 fibroblasts engineered to express a mutant colony-stimulating factor (CSF-1) receptor Mammalian D-and E-type cyclins assemble with cyclindependent kinases (cdks) to form holoenzymes, whose activities are rate limiting for progression through the G1 phase of the cell cycle (1-3). Cyclin E expression is periodic and maximal at the G1 to S phase transition, where it regulates the activity of cdk2 (4, 5), a catalytic subunit whose functions are necessary for the onset of DNA replication (6-8). As cells enter the cycle following mitogenic stimulation, D-type cyclins (Dl, D2, and D3) are expressed earlier than cyclin E in a lineage-specific manner (9), assemble into complexes with cdk4 and cdk6 (10-14), and execute their functions prior to the G1/S transition (2, 9, 15). A critical substrate of the cyclin D-dependent kinases is likely to be the retinoblastoma protein
either of three D-type cyclin genes, but not cyclin E, resensitized these cells to the mitogenic effects of CSF-1, enabling them to proliferate continuously in liquid culture and to form colonies in agar in response to the growth factor. Rescue by cyclin Dl was enhanced by c-myc but not by cyclin E and was reversed by infecting cyclin DI-reconstituted cells with a retroviral vector encoding catalytically inactive cyclindependent kinase 4. Induction of cyclin Dl mRNA by CSF-1 was restored in cells forced to express c-myc, and vice versa, suggesting that expression of the two genes is interdependent. Cells reconstituted with c-myc were prevented from entering S phase when microinjected with a monoclonal antibody to cyclin Dl, and conversely, those rescued by cyclin Dl were inhibited from forming CSF-1-dependent colonies when challenged with a dominant-negative c-myc mutant. Cyclin D mutants defective in binding to the retinoblastoma protein were impaired in rescuing mitogenic signaling. Therefore, Myc and D-type cyclins collaborate during the mitogenic response to CSF-1, whereas cyclin E functions in a separate pathway.
Mammalian D-and E-type cyclins assemble with cyclindependent kinases (cdks) to form holoenzymes, whose activities are rate limiting for progression through the G1 phase of the cell cycle (1) (2) (3) . Cyclin E expression is periodic and maximal at the G1 to S phase transition, where it regulates the activity of cdk2 (4, 5) , a catalytic subunit whose functions are necessary for the onset of DNA replication (6) (7) (8) . As cells enter the cycle following mitogenic stimulation, D-type cyclins (Dl, D2, and D3) are expressed earlier than cyclin E in a lineage-specific manner (9), assemble into complexes with cdk4 and cdk6 (10) (11) (12) (13) (14) , and execute their functions prior to the G1/S transition (2, 9, 15) . A critical substrate of the cyclin D-dependent kinases is likely to be the retinoblastoma protein (pRb) (10, 12, 13, 16) , whose phosphorylation late in GI reverses its growth-suppressive function (17) (18) (19) (20) . Cyclin Dl appears not to be required in pRb-negative cells (21-23) .
In macrophages, colony-stimulating factor 1 (CSF-1) initiates a mitogenic response by binding to the CSF-1 receptor (CSF-1R), thereby activating the receptor protein tyrosine kinase and signaling via multiple effector-mediated pathways. CSF-1 is required throughout G1 to ensure entry of macrophages into S phase, and persistent CSF-1R kinase activity is necessary for the expression of both immediate early-e.g., c-fos, c-jun, and c-myc-and delayed early-e.g., D-type cyc-
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lins-response genes. Ligand-activated human CSF-1R can induce continuous proliferation when ectopically expressed in mouse NIH 3T3 fibroblasts, replacing their requirement for platelet-derived growth factor and insulin-like growth factor 1 (24). In contrast, a receptor mutant containing a phenylalanine for tyrosine substitution at codon 809 (here designated CSF-1R 809F) is mitogenically inactive (25), and ligandstimulated cells remain arrested in early G1 phase (26). Although cells expressing CSF-1R 809F exhibit receptor kinase activity and unimpaired fos and jun expression (25), c-myc is poorly induced, and expression of its mRNA is unsustained.
Enforced expression of c-myc in these cells overcomes G, arrest and restores the proliferative response, demonstrating that c-myc is required for CSF-1 induced mitogenesis (27) . Because expression of c-myc, like that of D-and E-type cyclins, is rate limiting for G1 progression (28, 29), these genes might collaborate during the mitogenic response. To that end, we assayed the ability of G1 cyclins to rescue CSF-1 responsiveness in cells bearing the CSF-1R 809F mutant.
MATERIALS AND METHODS
Expression Plasmids. Cyclin D expression plasmids were constructed as described (2) . Cyclin Dl and D2 mutants disrupted in the LXCXE motif necessary for pRb binding but able to interact with cdk4 (16, 30-32) included pentapeptide deletions (ALXCXE) and mutation of glutamic acid-7 in cyclin D2 to lysine (D2-E7K) (32). A retrovirus vector encoding human cyclin E (1) was provided by James Roberts (Fred Hutchinson Cancer Center, Seattle) and a plasmid conferring resistance to puromycin (pJ6fQ-puro) was provided by Hartmut Land (Imperial Cancer Research Fund, London (400 ,ug/ml) and puromycin (7.5 ,ug/ml). Replicationdefective retroviral vectors encoding cyclin E, c-myc (1n373), and cdk4 (K35M) were pseudotyped in 293T cells (a gift from David Baltimore, Massachusetts Institute of Technology) (34), and harvested virions were used to infect cells expressing CSF-1R or their derivatives. Infections were performed with unfrozen virus stocks at multiplicities >1 per cell, and cells were assayed for protein expression or CSF-1 responsiveness 72 h postinfection.
Polyclonal populations derived from virus-infected cells or from hundreds of puromycin-and G418-resistant colonies were seeded into semisolid medium (27, 38) in the absence or presence of 0.1 ,ug of purified human recombinant CSF-1 per ml (provided by Steve Clark, Genetics Institute, Cambridge, MA). Colonies derived from single cells were expanded and retested for CSF-1-dependent growth, reanalyzed for cyclin D expression, and assayed for their ability to proliferate in chemically defined medium containing human recombinant CSF-1 as the only added growth factor (24). Cells bearing wild-type CSF-1R and "rescued" clones expressing CSF-1R 809F and D-type cyclins proliferated at similar rates, with a doubling time of -22 h. For studies of synchronous S phase entry, cells grown to confluence for 2 days were starved for 18 h in medium containing 0.1% fetal calf serum, trypsinized, and replated at 60% confluence in either chemically defined medium containing CSF-1 or in DMEM plus 10% fetal calf serum. Entry into S phase was monitored by flow cytometric analysis of DNA content (9) and by analysis of BrdUrd incorporation into DNA (2) .
Microinjection Studies. Quiescent cells on coverslips (60% confluence) were microinjected at pressures between 50 and 150 hPa (AIS Zeiss settings: angle "45," speed "10," and time "0.0" sec) (39) in 3.5-cm Petri dishes containing 3 ml of carbonate-free DMEM to avoid a decrease in pH. Immediately after injection, cells were stimulated with recombinant CSF-1 in serum-free medium containing BrdUrd (100 t,M), and its incorporation into DNA was monitored 24 h later. Coverslips were rinsed in phosphate-buffered saline (PBS), fixed 10 min at -20°C in methanol:acetone (1:1), washed three times with PBS, and processed for immunofluorescence (15). Mouse mAbs to cyclin Dl were detected with biotinylated horse antibody to mouse IgG and Texas red-conjugated streptavidin, whereas BrdUrd was detected with a 1:50 dilution of sheep anti-BrdUrd followed by FITC-conjugated anti-sheep IgG or directly with undiluted FITC-mAb to BrdUrd. Counterstaining for DNA was performed by adding 1 ,ug of bisbenzimide (Hoechst 33258) per ml to the final PBS wash. The percent inhibition of BrdUrd incorporation was calculated as N -I/N x 100, where N is the percent BrdUrd incorporation into 100 injected cells and I is the percent incorporation into 100 cells injected with mAb or control IgG. The numerical value is independent of experimental variations in the number of noninjected BrdUrd-positive cells. (2) , but the levels of exogenous cyclin Dl synthesis in transfected cells growing in serum-containing medium were 8-to 10-fold higher than those of the endogenous protein (Fig. 2X) ; equally high levels of ectopic expression of cyclins D2 and D3 were obtained ( Fig. 2 B and C). Colonies picked at random, when grown up and reanalyzed, each expressed high levels of cyclin D (Fig. 2 D (Fig. 1 ) or in cells infected with either dominant-negative c-myc (1n373) or cdk4 (K35M) mutants were characteristically much smaller than those obtained with cyclin D or c-myc alone. Representative colonies arising from cells expressing D-type cyclins expressed high levels of the proteins (Fig. 2) and formed CSF-1-dependent colonies in agar at -50% greater efficiencies when replated.
efficiencies about 50% greater than those of uncloned, parental transformants. Cyclin D synthesis was readily detected in growth factor-deprived transformants and at high levels throughout the cell cycle (Fig. 2F) , and the cells expressed greatly elevated levels of cyclin D-dependent pRb kinase activity (Fig. 2G) .
cdk4 interacts only with D-type cyclins (10, 16), and a catalytically inactive cdk4 mutant (K35M) was previously shown to reverse the phenotypic effects of cyclin D overexpression in vivo, where it presumably acts as a dominantnegative by sequestering cyclin D into inactive holoenzyme complexes (32). cdk4 (K35M) significantly inhibited colony formation in cells expressing wild-type CSF-1R and in CSF-1R 809F-bearing cells reconstituted by cyclin Dl (Table 1) , verifying that CSF-1 responsiveness required the continuous presence of cyclin D.
Cells overexpressing cyclin D mutants disrupted in an N-terminal LXCXE pentapeptide necessary for pRb binding but not for cdk4 activation formed only few slowly growing colonies ( Fig. 1 E and F ; Table 1 ). Ectopic expression of the cyclin Dl ALXCXE mutant was equal to that of endogenous cyclin Dl (Fig. 24) , and the two biologically impaired mutant cyclin D2 proteins were produced in much greater amounts, approximating that of the ectopically expressed wild-type cyclin D2 gene product (Fig. 2B) . Cells infected with a retrovirus encoding human cyclin E (1) also synthesized high levels of the corresponding protein (Fig. 2H, +E) , as did representative single cell-derived subclones obtained by end point dilution (clones El and E2). During continuous passage in culture, the levels of ectopic cyclin E synthesis in the uncloned population increased gradually (Fig. 21) , implying Results are shown with uncloned populations (A-C) and with numbered subclones derived from agar colonies (D and E). Cells transfected with the Dl ALXCXE mutant expressed a faster-migrating form of the protein (A), whereas the differences in mobility are less apparent for the more abundantly expressed D2 mutants (B). F demonstrates that cyclin Dl synthesis is constitutive throughout the cell cycle. Less than 5% of starved cells (time 0) were in S phase, and stimulated cells entered S phase synchronously with 24% in S phase by 10 h and >80% completing the cycle by 22 h. Cyclin Dl immune complexes prepared from untransformed cells (lanes 809F and WT) or from those expressing the indicated genes were tested for associated pRb kinase activity (G). At the exposure shown (30 min), little pRb kinase activity can be observed in cells expressing CSF-1R alone, but somewhat higher levels are observed in cells overexpressing c-myc. Human cyclin E overexpression (H and I) in a polyclonal population (+E) and in two subclones (El and E2) was documented by immunoblotting, but endogenous rodent cyclin E was not detected. Cells at different passage numbers (I) accumulated more cyclin E but failed to form colonies in agar.
positive selection for cells overproducing the protein. These cells also exhibited a robust cyclin E-associated histone Hi kinase activity that was >10-fold that detected in nontransfected controls (data not shown). Neither the passaged cyclin E-infected cells nor their subclones formed colonies in agar in response to CSF-1 (Table 1) , and unlike cyclin D transformants, they did not proliferate in serum-free medium containing the recombinant growth factor. Collaboration Between Cyclin Dl and c-myc. Because both cyclin D1 and c-myc rescued the CSF-1 response, we attempted to determine whether their activities were interdependent. Fibroblasts expressing wild-type CSF-1R or CSF-1R 809F were grown to confluence, starved in 0.1% serum, and then replated and stimulated either with fresh medium containing 10% serum or with serum-free medium containing human recombinant CSF-1. Both c-myc and cyclin Dl mRNA expression were induced by serum, but while cells expressing wildtype receptor responded to CSF-1 (Fig. 3A) , those bearing CSF-1R 809F exhibited only weak transient induction of both mRNAs (Fig. 3B) . More than 80% of cells expressing wild-type CSF-1R entered S phase in the first cycle after CSF-1 stimulation. In contrast, less than 9% of stimulated cells expressing CSF-1R 809F incorporated BrdUrd or expressed nuclear cyclin Dl (data not shown), with <0.1% of the latter yielding colonies in agar (see Table 1 ). Although c-myc and cyclin Dl are not appreciably expressed in quiescent cells (9, 27), cyclin Dl mRNA and protein synthesis were restored in CSF-1R 809F-bearing cells reconstituted with c-myc in a manner indistinguishable from that seen in cells expressing wild-type CSF-1R (see Fig. 3A ; data not shown). Conversely, c-myc was induced by CSF-1 in cells forced to produce cyclin Dl (Fig.  3C ). In four independent experiments, the maximal levels of c-myc mRNA induced in the first cycle in response to CSF-1 were 63% ± 17% lower than those obtained after serum treatment, when corrected for RNA loading by the use of a control actin probe. Nonetheless, both populations entered S phase at similar rates as judged by BrdUrd labeling (data not shown). Because the exogenous cyclin Dl mRNA species lacks most of its 3' untranslated region, it was readily distinguished from endogenous cyclin Dl mRNAs (Fig. 3C ). Constitutive expression of the exogenous cyclin Dl gene also restored growth factor-induced synthesis of endogenous cyclin Dl mRNA (Fig. 3C) .
To determine if c-myc-rescued cells still depended upon cyclin Dl function for entry into S phase, quiescent cells were microinjected with antibodies to cyclin Dl and restimulated with recombinant CSF-1 in serum-free medium to reenter the cell cycle. BrdUrd was added with CSF-1, and its incorporation into DNA was determined 24 h later. Two monoclonal antibodies to cyclin Dl prevented S phase entry in cells bearing wild-type receptors, as well as in those rescued by either cyclin Dl or c-myc, whereas control IgG was without significant effect (Fig. 4) .
It is unlikely that cyclin Dl simply acts downstream of Myc to bypass its function(s). Cotransfection of cyclin Dl and c-myc into cells expressing CSF-1R 809F reproducibly yielded a higher frequency of CSF-1-dependent colonies than either gene alone, indicating that their effects were additive (Table  1) to rapid cyclin D degradation correlating with the failure of cells to enter S phase, but its degradation after G1/S has no effect on progression through the remainder of the cycle (9). Overexpression of D-type cyclins in fibroblasts shortens their G, interval, whereas microinjection of antibodies to cyclin Dl can prevent entry into S phase, as long as injections are performed prior to the G1/S transition (2, 15 53.
